ConductScience.org, home

Paper36915146

Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.

Ibarra-Estrada M and 11 others. Crit Care, 2023. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Papers, record 36915146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915146

Download JSON
Disease
Sepsis231 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
PubMed
Journal
Crit Care
PubMed
Year
2023
PubMed
Publication types
Randomized Controlled Trial, Journal Article
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
9.54
iCite
Revised in PubMed
2023-11-23
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ibarra-Estrada MMiguelhttps://orcid.org/0000-0001-8914-4171
2Kattan EEduardo
3Aguilera-González PPavel
4Sandoval-Plascencia LLaura
5Rico-Jauregui UUriel
6Gómez-Partida CACarlos A
7Ortiz-Macías IXIris X
8López-Pulgarín JAJosé A
9Chávez-Peña QQuetzalcóatl
10Mijangos-Méndez JCJulio C
11Aguirre-Avalos GGuadalupe
12Hernández GGlenn

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Shock, SepticMajor topic
SepsisMajor topic
Humans
Methylene Blue
Vasoconstrictor Agents

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04446871Methylene Blue in Early Septic ShockDerived from the trialYesClinicalTrials.gov
NCT06306001Intravenous Methylene Blue for Treating Refractory Neonatal Septic ShockResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in37644588Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy.https://conductscience.org/library/papers/37644588PubMed
Comment in37670332Drug diluent and efficacy of methylene blue in septic shock: authors' reply.https://conductscience.org/library/papers/37670332PubMed

Download CSV of comments and corrections

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126125087NOREPINEPHRINE: NOT TOO MUCH, TOO LONG.Shock2015https://conductscience.org/library/papers/26125087PubMed
212500513The influence of methylene blue infusion on cytokine levels during severe sepsis.Anaesth Intensive Care2002https://conductscience.org/library/papers/12500513PubMed
331520103Less is more: catecholamine-sparing strategies in septic shock.Intensive Care Med2019https://conductscience.org/library/papers/31520103PubMed
414707556Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.Crit Care Med2004https://conductscience.org/library/papers/14707556PubMed
532520577Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis.Am J Respir Crit Care Med2020https://conductscience.org/library/papers/32520577PubMed
634582425Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.Crit Care Med2022https://conductscience.org/library/papers/34582425PubMed
720109575A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.Nitric Oxide2010https://conductscience.org/library/papers/20109575PubMed
88750129Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.Intensive Care Med1995https://conductscience.org/library/papers/8750129PubMed
926903338The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA2016https://conductscience.org/library/papers/26903338PubMed
1035311781Early Multimodal Vasopressors-Are We Ready for It?Crit Care Med2022https://conductscience.org/library/papers/35311781PubMed
1136398968Lower Versus Higher Exposure to Vasopressor Therapy in Vasodilatory Hypotension: A Systematic Review With Meta-Analysis.Crit Care Med2023https://conductscience.org/library/papers/36398968PubMed
1224078299Methylene blue does not have to be considered only as rescue therapy for distributive shock.J Med Toxicol2013https://conductscience.org/library/papers/24078299PubMed
1329347874Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.N Engl J Med2018https://conductscience.org/library/papers/29347874PubMed
1426683506Pharmacodynamic Analysis of a Fluid Challenge.Crit Care Med2016https://conductscience.org/library/papers/26683506PubMed
1532019600Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.Crit Care2020https://conductscience.org/library/papers/32019600PubMed
1626123610Respiratory variation in carotid peak systolic velocity predicts volume responsiveness in mechanically ventilated patients with septic shock: a prospective cohort study.Crit Ultrasound J2015https://conductscience.org/library/papers/26123610PubMed
1730410284Angiotensin II Brings More Questions Than Answers.P T2018https://conductscience.org/library/papers/30410284PubMed
1832705530Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.Adv Ther2020https://conductscience.org/library/papers/32705530PubMed
1932270211Noradrenaline drives immunosuppression in sepsis: clinical consequences.Intensive Care Med2020https://conductscience.org/library/papers/32270211PubMed
209869542Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.J Crit Care1998https://conductscience.org/library/papers/9869542PubMed

See all 45 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
42978844The potential role of methylene blue as an adjunctive therapy in septic shock.J Intensive Med2026https://conductscience.org/library/papers/42978844PubMed
42827248Targeting capillary leak in experimental sepsis and endotoxemia: a systematic review of therapeutic agents, methods and models in animal studies.Crit Care2026https://conductscience.org/library/papers/42827248PubMed
42719392Lung-Cardiovascular Interactions and Derangements in ARDS.Compr Physiol2026https://conductscience.org/library/papers/42719392PubMed
42565679Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.Proc (Bayl Univ Med Cent)2026https://conductscience.org/library/papers/42565679PubMed
42355649The Effectiveness of Methylene Blue in Adult Shock: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials.J Clin Med2026https://conductscience.org/library/papers/42355649PubMed
42277950Current and future strategies aiming at reducing catecholamine exposure in septic shock.Crit Care2026https://conductscience.org/library/papers/42277950PubMed
42110642Machine learning for prediction of in-ICU mortality in sepsis: an observational study using the MIMIC IV database.Arch Med Sci2026https://conductscience.org/library/papers/42110642PubMed
42090639Effect of Weight-based versus Absolute Norepinephrine Dosing on Mortality Risk in Obese Patients with Septic Shock: An Observational, Multicohort, Retrospective Study.Anesthesiology2026https://conductscience.org/library/papers/42090639PubMed
42088182Methylene blue: An adjunct therapy in shock patients in resource-poor settings.J Anaesthesiol Clin Pharmacol2026https://conductscience.org/library/papers/42088182PubMed
41959519Deciphering sepsis molecular subtypes using large-scale data to identify subtype-specific drug repurposing.bioRxiv2026https://conductscience.org/library/papers/41959519PubMed
41870560Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026.Intensive Care Med2026https://conductscience.org/library/papers/41870560PubMed
41805397A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock.Perfusion2026https://conductscience.org/library/papers/41805397PubMed
41731020A multimodal embedding model for sepsis data representation.NPJ Digit Med2026https://conductscience.org/library/papers/41731020PubMed
41580807Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trial.Scand J Trauma Resusc Emerg Med2026https://conductscience.org/library/papers/41580807PubMed
41477182The Effect of Methylene Blue on Sublingual Microcirculation in Patients with Septic Shock: A Randomized Controlled Trial.Drug Des Devel Ther2025https://conductscience.org/library/papers/41477182PubMed
41388310Management of post-resuscitation vasoplegic shock: targets, strategies and outcomes.Crit Care2025https://conductscience.org/library/papers/41388310PubMed
41377532Current and emerging therapeutic options for refractory septic shock: A systematic review.World J Crit Care Med2025https://conductscience.org/library/papers/41377532PubMed
41210023Use of Methylene Blue in Patients With Shock in the Intensive Care Unit Over a 10-Year Period at a Private Hospital in Costa Rica.Cureus2025https://conductscience.org/library/papers/41210023PubMed
41206424Use of Methylene Blue to Treat Hypotension in Poisoned Patients in the Toxicology Investigators Consortium (ToxIC) Core Registry: 2016-2023.J Med Toxicol2026https://conductscience.org/library/papers/41206424PubMed
41141023Methylene Blue for Refractory Shock Due to Acute Pancreatitis and Cholangitis.Cureus2025https://conductscience.org/library/papers/41141023PubMed

See all 52 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CHKA1119PubTator's text mininghttps://conductscience.org/library/genes/1119NCBI Gene
GGH8836PubTator's text mininghttps://conductscience.org/library/genes/8836NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
HBG23048PubTator's text mininghttps://conductscience.org/library/genes/3048NCBI Gene
NOS24843PubTator's text mininghttps://conductscience.org/library/genes/4843NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
METHYLENE BLUECHEMBL550495Results2https://conductscience.org/library/drugs/CHEMBL550495

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36915146

GET https://conductscience.org/api/papers/v1/36915146/references?page=2